W van der Flier
Overview
Explore the profile of W van der Flier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jessen F, Kramberger M, Angioni D, Aarsland D, Balasa M, Bennys K, et al.
J Prev Alzheimers Dis
. 2024 Oct;
11(5):1212-1218.
PMID: 39350366
β-amyloid-targeting antibodies represent the first generation of effective causal treatment of Alzheimer's disease (AD) and can be considered historical research milestones. Their effect sizes, side effects, implementation challenges and costs,...
2.
Hamel R, Kohler S, Sistermans N, Koene T, Pijnenburg Y, van der Flier W, et al.
Psychol Med
. 2014 Nov;
45(7):1509-19.
PMID: 25407094
Background: We investigated the course of decline in multiple cognitive domains in non-demented subjects from a memory clinic setting, and compared pattern, onset and magnitude of decline between subjects who...
3.
van Vliet P, Westendorp R, Eikelenboom P, Comijs H, Frolich M, Bakker E, et al.
Neurology
. 2009 Sep;
73(9):681-7.
PMID: 19720974
Background: Variation in APOE genotype is a determinant of Alzheimer disease (AD), but the risk associated with variation in plasma apoE levels has yet to be determined. Here, we studied...
4.
Karas G, Sluimer J, Goekoop R, van der Flier W, Rombouts S, Vrenken H, et al.
AJNR Am J Neuroradiol
. 2008 Feb;
29(5):944-9.
PMID: 18296551
Background And Purpose: Mild cognitive impairment (MCI) is considered by many to be a prodromal phase of Alzheimer disease (AD). We used voxel-based morphometry (VBM) to find out whether structural...